Researchers are closer to finding a better way to treat children with a rare metabolic disorder called MPS I

Researchers are closer to finding a better way to treat children with a rare metabolic disorder called MPS I. It is caused by a deficiency of the key enzyme IDUA needed to break down complex sugars in cells. MPS I eventually leads to the abnormal accumulation of sugar debris and cell death. The two main treatments are bone marrow transplantation and intravenous enzyme replacement therapy; however, both are only marginally effective or clinically impractical, especially when the disease enters the central nervous system (CNS). Read more here

http://www.uphs.upenn.edu/news/News_Releases/2016/07/wilson/

If you are interested about the clinic, please contact 256-327-9640 or fill out our contact form at https://smithfamilyclinic.org/contact/